We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTH icon
1576
Meritage Homes
MTH
$4.82B
$27K ﹤0.01%
898
+170
+23% +$5.83K
ONB icon
1577
Old National Bancorp
ONB
$10.3B
$27K ﹤0.01%
1,483
+221
+18% +$3.97K
PIO icon
1578
Invesco Global Water ETF
PIO
$270M
$27K ﹤0.01%
888
-300
-25% -$8.74K
ROCK icon
1579
Gibraltar Industries
ROCK
$1.3B
$27K ﹤0.01%
554
+100
+22% +$5.02K
SCHE icon
1580
Schwab Emerging Markets Equity ETF
SCHE
$12.2B
$27K ﹤0.01%
1,010
-2,598
-72% -$68.5K
GWB
1581
DELISTED
Great Western Bancorp, Inc.
GWB
$27K ﹤0.01%
815
-616
-43% -$21.3K
MGLN
1582
DELISTED
Magellan Health Services, Inc.
MGLN
$27K ﹤0.01%
361
+56
+18% +$3.94K
AVP
1583
DELISTED
Avon Products, Inc.
AVP
$27K ﹤0.01%
4,957
+796
+19% +$3.7K
TELN
1584
DELISTED
TELENOR ASA
TELN
$27K ﹤0.01%
1,547
+85
+6% +$1.48K
ABG icon
1585
Asbury Automotive
ABG
$4.67B
$26K ﹤0.01%
234
-135
-37% -$14.5K
BGC icon
1586
BGC Group
BGC
$5.69B
$26K ﹤0.01%
4,500
– –
BMRN icon
1587
BioMarin Pharmaceuticals
BMRN
$11.9B
$26K ﹤0.01%
314
– –
BOOT icon
1588
Boot Barn
BOOT
$4.6B
$26K ﹤0.01%
612
+95
+18% +$3.75K
DBC icon
1589
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$26K ﹤0.01%
1,656
-418
-20% -$6.49K
DBRG icon
1590
DigitalBridge
DBRG
$2.93B
$26K ﹤0.01%
1,410
– –
GIL icon
1591
Gildan
GIL
$9.48B
$26K ﹤0.01%
898
+400
+80% +$11.7K
GS.PRD icon
1592
Goldman Sachs Group Inc Series D Preferred Stock
GS.PRD
$1.01B
$26K ﹤0.01%
1,166
– –
ICF icon
1593
iShares Select U.S. REIT ETF
ICF
$2.12B
$26K ﹤0.01%
464
-2
-0.4% -$118
IRWD icon
1594
Ironwood Pharmaceuticals
IRWD
$596M
$26K ﹤0.01%
2,028
– –
ISRA icon
1595
VanEck Israel ETF
ISRA
$147M
$26K ﹤0.01%
750
– –
LPL icon
1596
LG Display
LPL
$2.79B
$26K ﹤0.01%
3,860
– –
MEOH icon
1597
Methanex
MEOH
$4.09B
$26K ﹤0.01%
688
– –
PKX icon
1598
POSCO
PKX
$14.8B
$26K ﹤0.01%
533
– –
SKYW icon
1599
Skywest
SKYW
$4.36B
$26K ﹤0.01%
409
+144
+54% +$8.77K
TPR icon
1600
Tapestry
TPR
$30.1B
$26K ﹤0.01%
969
-503
-34% -$13.1K
62 63
64
65 66

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.